GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo

We have previously demonstrated that estrogen receptor (ER) alpha (ESR1) increases proliferation of adrenocortical carcinoma (ACC) through both an estrogen-dependent and -independent (induced by IGF-II/IGF1R pathways) manner. Then, the use of tamoxifen, a selective estrogen receptor modulator (SERM)...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Chimento, Adele, Sirianni, Rosa, Casaburi, Ivan, Zolea, Fabiana, Rizza, Pietro, Avena, Paola, Malivindi, Rocco, De Luca, Arianna, Campana, Carmela, Martire, Emilia, Domanico, Francesco, Fallo, Francesco, Carpinelli, Giulia, Cerquetti, Lidia, Amendola, Donatella, Stigliano, Antonio, Pezzi, Vincenzo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2015
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4662484/
https://ncbi.nlm.nih.gov/pubmed/26131713
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller